HDAC8在坏死性小肠结肠炎中通过调控铁死亡及炎症反应发挥作用的机制研究OA
The Mechanism of HDAC8 in Necrotizing Enterocolitis by Regulating Ferroptosis and Inflammatory Response
目的 探讨组蛋白去乙酰酶8(histone deacetylase 8,HDAC8)抑制剂PCI-34051对坏死性小肠结肠炎(necrotizing enterocolitis,NEC)小鼠肠道损伤的保护作用及其与铁死亡(Ferroptosis)的关系,并通过体外实验进一步验证HDAC8在肠上皮细胞铁死亡中的作用机制.方法 选取40只出生8~11 d SPF级雄性C57BL/6小鼠,随机分为对照组、NEC 组、HDAC8 低表达组(NEC+PCI-34051)、HDAC8 低表达+Erastin 组(NEC+PCI-34051+Erastin)及NEC+Erastin组(每组8只).采用缺氧加冷应激法建立NEC模型,给予HDAC8抑制剂PCI-34051(20mg/kg)及/或铁死亡诱导剂Erastin(40 mg/kg)腹腔注射,每日1次,共14 d.检测肠道组织病理学变化、氧化应激及炎症指标、铁死亡相关蛋白(SLC7A11、GPX4、p53)表达及线粒体超微结构.同时采用小鼠肠上皮细胞系IEC-6进行体外实验,分为对照组、Erastin组、HDAC8低表达组(PCI-34051)、HDAC8过表达组(ADV-HDAC8)及HDAC8 低表达+SLC7A11 敲低组.通过 qRT-PCR 与 Western blot 检测 HDAC8、SLC7A11、GPX4 及ACSL4的表达,并检测细胞活性变化.结果 与对照组相比,NEC组小鼠肠道结构紊乱,炎性细胞浸润明显,GSH 下降(P<0.001),MDA、ROS 及 Fe2+升高(P<0.001),SLC7A11 和 GPX4 表达下降(P<0.001),p53 升高(P<0.001);HDAC8低表达组肠道组织损伤明显减轻,GSH表达增加,MDA、ROS及Fe2+降低,SLC7A11和GPX4表达增加,p53降低(P<0.001).Erastin干预可部分逆转PCI-34051的保护作用.体外实验结果一致:Erastin诱导IEC-6细胞铁死亡,HDAC8抑制上调SLC7A11和GPX4并提高细胞活性,而HDAC8过表达或SLC7A11敲低均增强铁死亡表型(P<0.001).结论 HDAC8抑制剂PCI-34051可通过上调SLC7A11/GPX4、抑制p53信号通路,减轻NEC小鼠及肠上皮细胞的氧化应激、炎症反应及线粒体损伤,其保护作用与抑制铁死亡密切相关.
Objective To investigate the protective effect of histone deacetylase 8(HDAC8)inhibitor PCI-34051 on intestinal injury in a mouse model of necrotizing enterocolitis(NEC)and its relationship with ferroptosis,and to further validate the mechanism of HDAC8 in ferroptosis of intestinal epithelial cells through in vitro experiments.Methods Forty 8-11day-old male SPF-grade C57BL/6 mice were randomly divided into five groups(n=8 per group):a control group,an NEC group,an HDAC8 low-expression group(NEC+PCI-34051),an HDAC8 low-expression+Erastin group(NEC+PCI-34051+Erastin),and an NEC+Erastin group(8 mice per group).An NEC model was established by hypoxia-cold stress.The HDAC8 inhibitor PCI-34051(20 mg/kg)and/or ferroptosis inducer Erastin(40 mg/kg)were administered intraperitoneally once daily for 14 days.Intestinal histopathological changes,oxidative stress and inflammatory markers,expression of ferroptosis-related proteins(SLC7A11,GPX4,p53),and mitochondrial ultrastructure were detected.In parallel,in vitro experiments were conducted using the mouse intestinal epithelial cell line IEC-6,which were divided into a control group,an Erastin group,an HDAC8 low-expression group(PCI-34051),an HDAC8 over-expression group(ADV-HDAC8),and an HDAC8 low-expression+SLC7A11 knockdown group.The expression of HDAC8,SLC7A11,GPX4,and ACSL4 was detected by qRT-PCR and Western blot,and changes in cell viability were assessed.Results Com-pared with the control group,the NEC group exhibited intestinal structural disorder,significant inflammatory cell infiltration,decreased GSH(P<0.001),elevated MDA,ROS,and Fe2+(P<0.001),reduced SLC7A11 and GPX4 expression(P<0.001),and increased p53(P<0.001).The HDAC8 low-expression group showed significantly reduced intestinal tissue damage,increased GSH expression,decreased MDA,ROS,and Fe2+,increased SLC7A11 and GPX4 expression,and decreased p53(P<0.001).Erastin intervention partially reversed the protective effect of PCI-34051.Consistent in vitro results demonstrated that Erastin induced ferroptosis in IEC-6 cells,HDAC8 inhibited the upregulation of SLC7A11 and GPX4 and enhanced cell viability,while HDAC8 overexpression or SLC7A11 knockdown both enhanced the ferroptotic phenotype(P<0.001).Conclusion The HDAC8 inhibitor PCI-34051 alleviates oxidative stress,inflammatory response and mitochondrial damage in NEC mice and intestinal epithelial cells by upregulating SLC7A11/GPX4 and inhibiting the p53 signaling pathway.Its protective effect is closely related to the inhibition of ferroptosis.
郎兴;高宇光;马新生;李静涛;魏建新
邯郸市中心医院儿外二科,河北邯郸 056000邯郸市中心医院儿外二科,河北邯郸 056000邯郸市中心医院儿外二科,河北邯郸 056000邯郸市中心医院儿外二科,河北邯郸 056000邯郸市中心医院儿外二科,河北邯郸 056000
医药卫生
坏死性小肠结肠炎组蛋白去乙酰化酶8铁死亡溶质载体家族7成员11谷胱甘肽过氧化物酶4炎性因子
Necrotizing enterocolitisHDAC8FerroptosisSLC7A11GPX4Inflammatory factors
《昆明医科大学学报》 2026 (3)
34-44,11
河北省医学科学研究基金(20231979)
评论